Antibody response elicited by SARS-CoV-2 vaccines. by Chris Davis (647632)

Lung tumor development decreases the proportions of CD103⁺XCR1⁺ DC1s. by Julyanne Brassard (4117441)

The deletion of the <i>pflB</i> gene led to decreased invasion efficiency in the Caco-2 cell line, which corresponded to a reduced organ burden in C57BL/6 mice five days after infection through oral gavaging. by Debapriya Mukherjee (9961289)

Th2 cytokines and IgE were decreased in G-1-treated C57BL/6 mice compared to non-treated mice. by Masamichi Itoga (706167)

Cumulative and S-, N- and M- specific SARS-CoV-2 specific T cell frequencies are elevated in PASC. by Katherine M. Littlefield (12647420)

Models of G48D, M78I, G125C, and A146V RAD52 point mutants. by Abdulaziz B. Hamid (13804692)

<i>Pbpp6</i> gene deletion/disruption and analysis. by Yonghui Feng (12227596)

Resveratrol decreased tumor latency in <i>Sirt1^Y/+</i> mice. by Katherine V. Clark-Knowles (368164)

Glu58 and Arg87 minimal distance decreases upon activation. by Maxime Louet (150102)

The AMPK inhibitor CC exacerbates palmitate-induced decreases in viability. by Dustin M. Lee (8207457)

Total amounts of innate immune signaling pathway proteins are not globally decreased. by Justine Levan (4579156)

RT-qPCR analysis of congenital diaphragmatic hernia lungs showed an increase in distal epithelial progenitor and a decrease in type 1 alveolar cells. by Tram Mai Nguyen (6597863)

“…<p>E17.5 CDH lungs demonstrated a decrease in mRNAs identifying alveolar epithelial type I cells (<i>Hopx</i>, <i>Pdpn</i>) while distal epithelial progenitor marker <i>Id2</i> was increased. …”

Eltrombopag markedly decreases levels of ROS in MOLM14 cells. by Anna Kalota (7415)

“…B) Graphic presentation of ROS levels measured by flow cytometry in cells treated with E (5 μM) or DPI (25 μM), an inhibitor of NADPH oxidase known to decrease an intracellular level of ROS, or untreated (CTR) cells. …”

cGAS inhibition decreases ISG RNA in H358 cells. by Lorellin A. Durnell-Bettis (22656332)

P2X7 is functionally expressed in the ovarian carcinoma cell line SKOV-3. by José David Nuñez-Ríos (18823719)

Subjects:

M344 decreases orthotopic pancreatic tumor growth when used as a treatment alone or in combination with gemcitabine. by Shelby M. Knoche (13833807)

LD- and haplotype-based measures of epistasis identify a narrow time window of epistasis detectability. by Gabriele Pedruzzi (5753792)

MCM-BP can decrease phosphorylation by DDK but is not a substrate. by Tin Nguyen (231591)

Compared to vorinostat, M344 decreases pancreatic cancer cell proliferation more effectively for a longer duration. by Shelby M. Knoche (13833807)

Effects of Kylo-0603 on body weight, organ weight, and body fat content. by Xueqin lu (22250795)